Literature DB >> 11847183

Association between pulse pressure and C-reactive protein among apparently healthy US adults.

Jerome L Abramson1, William S Weintraub, Viola Vaccarino.   

Abstract

Elevated pulse pressure has been associated with an increased risk of cardiovascular disease, which is increasingly being seen as an inflammatory disease. Thus, the mechanism underlying the link between elevated pulse pressure and cardiovascular disease risk may be inflammation. However, investigators have not examined the relationship between pulse pressure and C-reactive protein, an inflammation marker that has been closely linked to cardiovascular risk. We examined the cross-sectional relationship between pulse pressure and C-reactive protein among 9867 healthy persons 17 years of age or older who participated in the Third National Health and Nutrition Examination Survey. The association between pulse pressure and the odds of having an elevated C-reactive protein level (> or = 0.66 mg/dL) was assessed by logistic regression. In a model that adjusted for systolic blood pressure, demographic factors, cholesterol, measures of obesity, smoking, alcohol consumption, physical activity, and antihypertensive medication use, a 10 mm Hg increase in pulse pressure was associated with a 15% increase in the odds of having an elevated C-reactive protein level (odds ratio, 1.15; 95% confidence interval, 1.01 to 1.31; P=0.04). When the same model was re-run adjusting for diastolic blood pressure instead of systolic blood pressure, a 10 mm Hg rise in pulse pressure was associated with a significant 12% increase in the odds of having an elevated C-reactive protein level. Systolic and diastolic blood pressure were unrelated to C-reactive protein once pulse pressure had been accounted for. Our results suggest that increases in pulse pressure are associated with elevated C-reactive protein levels among apparently healthy US adults, independent of systolic and diastolic blood pressure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11847183     DOI: 10.1161/hy0202.104270

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  26 in total

Review 1.  Systolic pressure, diastolic pressure, or pulse pressure as a cardiovascular risk factor in renal disease.

Authors:  José A García-Donaire; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

2.  Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors?

Authors:  E DeVallance; S B Fournier; D A Donley; D E Bonner; K Lee; J C Frisbee; P D Chantler
Journal:  Int J Obes (Lond)       Date:  2014-06-24       Impact factor: 5.095

3.  Effects of resistance training on central blood pressure in obese young men.

Authors:  D M Croymans; S L Krell; C S Oh; M Katiraie; C Y Lam; R A Harris; C K Roberts
Journal:  J Hum Hypertens       Date:  2013-09-05       Impact factor: 3.012

4.  Increase in pulse pressure on administration of a dental local anesthetic solution, prilocaine hydrochloride with felypressin in male diabetic patients with coronary heart disease.

Authors:  Kazumasa Kubota; Yuka Kyosaka; Kaori Ueda; Shunsuke Minakuchi
Journal:  Clin Oral Investig       Date:  2019-05-12       Impact factor: 3.573

Review 5.  C-reactive protein: the pawn has been promoted to queen.

Authors:  Edward T H Yeh; Robert P Palusinski
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

Review 6.  Metabolic syndrome X: an inflammatory condition?

Authors:  Undurti N Das
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

7.  Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents.

Authors:  Marc B Lande; Thomas A Pearson; Roger P Vermilion; Peggy Auinger; Isabel D Fernandez
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

8.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

9.  Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection.

Authors:  Renate Schnabel; Martin G Larson; Josée Dupuis; Kathryn L Lunetta; Izabella Lipinska; James B Meigs; Xiaoyan Yin; Jian Rong; Joseph A Vita; Christopher Newton-Cheh; Daniel Levy; John F Keaney; Ramachandran S Vasan; Gary F Mitchell; Emelia J Benjamin
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

10.  Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study.

Authors:  Wolfgang Lieb; Martin G Larson; Emelia J Benjamin; Xiaoyan Yin; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Thomas J Wang; Joseph A Vita; Daniel Levy; Ramachandran S Vasan; Gary F Mitchell
Journal:  Circulation       Date:  2008-12-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.